IPAD-DB ID | D00076 |
Name | Nadolol |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 7 H 2 7 N O 4 |
Molecular Weight | 309.4 g/mol |
IUPAC Name | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol |
InChI | InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1 |
InChIKey | VWPOSFSPZNDTMJ-UCWKZMIHSA-N |
Canonical SMILES | CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O |
PubChem CID | 39147 |
DrugBank Accession Number | DB01203 |
CAS Registry Number | 220045-89-6 |
Molecular Weight(Computed by SwissADME) | 309.4 |
Hac(Computed by SwissADME) | 22 |
Volume(Computed by ADMETlab 2.0) | 323.724 |
Density(Computed by ADMETlab 2.0) | 0.955 |
nRing(Computed by ADMETlab 2.0) | 2 |
MaxRing(Computed by ADMETlab 2.0) | 2 |
nHet(Computed by ADMETlab 2.0) | 5 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 11 |
Flexibility(Computed by ADMETlab 2.0) | 0.545 |
Stero Centers(Computed by ADMETlab 2.0) | 3 |
LogS(Computed by ADMETlab 2.0) | -1.979 |
LogD(Computed by ADMETlab 2.0) | 1.379 |
logP(Computed by ADMETlab 2.0) | 1.363 |
TPSA(Computed by SwissADME) | 81.95 |
Hbond Acceptor(Computed by SwissADME) | 5 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 6 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.68 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |